Table 1.
Characteristics of the studies included in the analysis.
| Publication date | Authors | Journal | Location | Study Type | Infected population | Obesity (%) | COVID-19 severity | Complications (%) | Hospitalization (%) | Mortality (%) |
|---|---|---|---|---|---|---|---|---|---|---|
| 04/25/2020 | Muscogiuri G; et al. | Metabolism 2020; 2020:1−12. | Naples, Italy | Systematic Review | 899 | 617 (68,6%) | Î | Î | Î | 471 (60,9%); Î |
| 04/26/2020 | Means C. | Metabolism 2020:108:154254. | Portland, USA | Systematic Review | Î | Î | ||||
| 03/31/2020 | Muniyappa R; et al. | Journal Physiol Endocrinol Metab 318(5):E736-E741. | Bethesda, Maryland, USA | Systematic Review | Î | Î | ||||
| 04−03-2020 | Severin R; et al. | Am J Med 2020;S0002-9343(20)30347-8. | Chicago, USA | Systematic Review/ Guideline | Î | Î | ||||
| 04/27/2020 | Khider L; et al. | JMV-Journal de Médecine Vasculaire 2020;1-6. | Paris, France and Toronto, Canadá | Guideline | Î | Î | ||||
| 04/18/2020 | Gomez JC; et al. | Rev Clin Esp 2020; | Zafra, Spain | Integrative Review | Î | Î | ||||
| 04/28/2020 | Delgado-Roche L; et al. | Archives of Medical Research 2020;1-4. | Ciudade de México, México | Narrative Review | Î | Î | 50,2 (15,8%); Î | |||
| 04/22/2020 | Redd WD; et al. | Gastroenterology 2020;1-14 | Boston, USA | Cohort Study | 318 | Î | Î | 318 (100%) | 32 (10.1%) | |
| 04-08-2020 | Li M; et al | Nutr, Metab and Cardiov Dis 2020; | Wuhan, China | Cohort Study | 83 | 42 (50%) | Î | 25 (30,12%) | 6 (7,2%) | |
| 04/26/2020 | Allocca M; et al. | Clin Gastroenterol Hepatol 2020; S1542-3565(20)30616-9. | Milan, Italy and Paris, France | Cohort Study | 15 | 2 (13,33%) | 5 (33,33%) | |||
| 03/27/2020 | MC Michael TM; et al | N Engl J Med 2020;21;382(21):2005-2011. | Seattle; USA | Cohort Study | 167 | 37 (22,2%) | 66 (39,5%) | 35 (21,0%) | ||
| 04/28/2020 | Chen Q; et al. | Infection 2020; 28:1-9. | Zhejiang, China | Cohort Study | 145 | 42 (28,96%) | Î | Î | 145 (100%) | |
| 04-08-2020 | Nobel YR; et al. | Gastroenterology 2020. | New York, USA | Control Case Study | 278 | 90 (33%) | Î | Î | 260 (93,5%) | 9 (3,2%) |
| 04/24/2020 | Richa Dson S; et al. | JAMA 2020;323(20):2052-2059. | New York, USA | Case Series | 5700 | 2528 (44,4%) | Î | Î | 5700 (100%) | 553 (21%); Î |
| 04/17/2020 | ZhenG KI; et al. | Metabolism 2020;1-17. | Wenzhou, China | Case Series | 66 | 45 (68,2%) | Î | 19 (28,8%) | ||
| 04/17/2020 | UllaH W; et al. | J Am Coll Cardiol Case Rep 2020:1-4. | Pennsylvania, USA | Case Report | Î | Î | ||||
| 04/16/2020 | Rebelos E; et al. | Metabolism 2020;108:154247. | Milan and Pisa, Italy | Letter to the Editor | Î | |||||
| 04/26/2020 | Stefan N; et al. | Nat Rev Endocrinol 2020; 1–2. | Munich, Germany and Boston, USA | Comments | Î | Î | ||||
| 04-05-2020 | Luzi L; Radaelli MG. | Acta Diabetol 2020; 1–6. | Milan, Italy | Comments | Î | Î | ||||
| 04-11-2020 | Puig-Domingo M; et al. | Endocrine 2020;1–4. | Badalona, Spain and Milan, Italy | Comments | Î | Î | Î |